Cartesian Therapeutics Inc. (RNAC) valuation · rev $2.8M
Cartesian Therapeutics Inc. (RNAC) rev $2.8M.
| Metric | Value |
|---|---|
| Market cap | $290.9M |
| Revenue | $2.8M |
| P/S | 104.0 |
RNAC valuation FAQ
What is RNAC's market cap?
Cartesian Therapeutics Inc. (RNAC) market cap is $290.9M on the latest cached fundamentals snapshot.
What is RNAC's latest revenue?
Latest cached Cartesian Therapeutics Inc. (RNAC) revenue was $2.8M. Statements: https://lician.com/financials/rnac
What is RNAC's price-to-sales ratio?
Cartesian Therapeutics Inc. (RNAC) price-to-sales (P/S) is 104.0, cached market cap $290.9M divided by revenue $2.8M.
How many RNAC valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Cartesian Therapeutics Inc. (RNAC): Market cap, Revenue, and P/S.
Where is RNAC valuation listed?
Cached valuation multiples for Cartesian Therapeutics Inc. (RNAC) are listed at https://lician.com/valuation/rnac.
Not investment advice. Cached rows, not a live tape.